- Home
- ESPR vs PMO Comparison
ESPR vs PMO Comparison
Compare ESPR & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- PMO
- Stock Information
- Founded
- ESPR 2008
- PMO 1993
- Country
- ESPR United States
- PMO United States
- Employees
- ESPR N/A
- PMO N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- PMO Finance Companies
- Sector
- ESPR Health Care
- PMO Finance
- Exchange
- ESPR Nasdaq
- PMO Nasdaq
- Market Cap
- ESPR 305.0M
- PMO 308.4M
- IPO Year
- ESPR 2013
- PMO N/A
- Fundamental
- Price
- ESPR $1.58
- PMO $10.23
- Analyst Decision
- ESPR Buy
- PMO
- Analyst Count
- ESPR 7
- PMO 0
- Target Price
- ESPR $6.36
- PMO N/A
- AVG Volume (30 Days)
- ESPR 4.2M
- PMO 99.0K
- Earning Date
- ESPR 03-04-2025
- PMO 01-01-0001
- Dividend Yield
- ESPR N/A
- PMO 4.10%
- EPS Growth
- ESPR N/A
- PMO N/A
- EPS
- ESPR N/A
- PMO 0.42
- Revenue
- ESPR $332,314,000.00
- PMO N/A
- Revenue This Year
- ESPR $5.51
- PMO N/A
- Revenue Next Year
- ESPR $1.42
- PMO N/A
- P/E Ratio
- ESPR N/A
- PMO $24.38
- Revenue Growth
- ESPR 185.66
- PMO N/A
- 52 Week Low
- ESPR $1.47
- PMO $8.57
- 52 Week High
- ESPR $3.94
- PMO $10.68
- Technical
- Relative Strength Index (RSI)
- ESPR 41.48
- PMO 32.28
- Support Level
- ESPR $1.47
- PMO $10.36
- Resistance Level
- ESPR $1.61
- PMO $10.43
- Average True Range (ATR)
- ESPR 0.12
- PMO 0.11
- MACD
- ESPR 0.00
- PMO -0.05
- Stochastic Oscillator
- ESPR 28.21
- PMO 1.75
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About PMO Putnam Municipal Opportunities Trust
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.